Related Experiment Videos
Therapeutic parameters of methylprednisolone treatment for retinal photic injury in a rat model
1Department of Ophthalmology and Visual Sciences, University of Illinois, College of Medicine, Chicago 60612.
Abstract:
Methylprednisolone (MP) has been prescribed for the treatment of solar retinopathy presumably because of its anti-inflammatory effect. Recently, high doses of MP have been shown to ameliorate light-induced photoreceptor degeneration, and the mechanism of action was suggested to be the inhibition of lipid peroxidation. In this study we examined the dose-response effect and the effect of delayed treatment with MP in an established rat model of retinal photic injury. Animals received intraperitoneal injections of either MP (8, 160, or 320 mg/kg/day) or saline solution (as a control) for 2 days. Injections were started simultaneously with the commencement of light exposure or delayed for 6 or 24 h. The animals were sacrificed 6 days after light exposure, and the retinal damage was assessed by light microscopy and morphometric measurement of the outer nuclear layer (ONL) thickness. Morphologically and morphometrically, treatment with 8 mg/kg/day of MP was not effective, while treatment with 160 mg/kg/day caused better preserved photoreceptors and a thicker ONL compared with the controls (P less than 0.001). Animals administered with a dose of 320 mg/kg/day showed more severe damage to photoreceptors, resulting in a thinner ONL (P less than 0.05). When treatment with 160 mg/kg/day was delayed for 6 h, a similar efficacy as in the no-delay group was noted, but when treatment was delayed for 24 h, no beneficial effect was observed (P = 0.19). Our results demonstrated that early treatment with high doses of MP ameliorated retinal photic injury in rats.
Insights
High-dose methylprednisolone (MP) protects against light-induced retinal damage in rats. Early MP treatment at 160 mg/kg/day preserved photoreceptors, but higher doses or delayed treatment were less effective.
Area of Science:
- Ophthalmology
- Pharmacology
- Toxicology
Background:
- Methylprednisolone (MP) is used for solar retinopathy due to its anti-inflammatory properties.
- High-dose MP may inhibit lipid peroxidation, protecting against light-induced photoreceptor degeneration.
Purpose of the Study:
- To investigate the dose-response and delayed treatment effects of MP on retinal photic injury in a rat model.
Main Methods:
- Rats received MP (8, 160, or 320 mg/kg/day) or saline intraperitoneally for 2 days.
- Treatment started simultaneously with light exposure or was delayed by 6 or 24 hours.
- Retinal damage was assessed via light microscopy and outer nuclear layer (ONL) thickness measurement 6 days post-exposure.
Main Results:
- 160 mg/kg/day MP significantly preserved photoreceptors and increased ONL thickness compared to controls (P < 0.001).
- 8 mg/kg/day MP was ineffective; 320 mg/kg/day MP worsened photoreceptor damage (P < 0.05).
- Delayed treatment with 160 mg/kg/day MP was effective at 6 hours but not at 24 hours (P = 0.19).
Conclusions:
- Early, high-dose methylprednisolone (160 mg/kg/day) effectively ameliorates light-induced retinal photic injury in rats.
- Optimal therapeutic benefit requires timely administration, with efficacy diminishing significantly after 6 hours.